Results 71 to 80 of about 21,823 (236)
Association of Glucagon‐Like Peptide—1 Receptor Analogues and Laryngeal Symptoms in Obese Adults
Table 1 succinctly quantifies the time‑dependent association between GLP‑1RA/GIP therapy and laryngeal symptoms, demonstrating modest but statistically robust increases in outcomes such as cough and voice/resonance disorders by 6 months. It provides clinically actionable absolute risks, odds ratios, and hazard ratios that can directly inform counseling,
Priyanka Shah +4 more
wiley +1 more source
Comprehensive pharmaco-neurological treatment of dysphonia as a result of cervical spine pathology
Background. Currently, there is a gradual increase in the number of cases of dysphonia. In individuals whose professional activities involve significant vocal strain, such as teachers, singers, etc., dysphonia may occur 1.4 times more frequently than in ...
D. A. Shakurova, I. V. Soloveva
doaj +1 more source
Pitch Strength & Percent Vocal Creak to Assess Treatment Response in Adductor Laryngeal Dystonia
Pitch Strength (PS) and Percent Vocal Creak (%VC) were measured before and after botulinum neurotoxin treatment in patients with adductor laryngeal dystonia (AdLD). While PS and %VC correlated with changes in disruption frequency and perceptual severity, they did not demonstrate robust group‐level treatment sensitivity.
Jesse D. Hoffmeister +5 more
wiley +1 more source
Verbal communication disorders in psychogenic dysphonia [PDF]
Psychogenic dysphonia is defined as disturbances in voice and speech quality with emotional background with lack of organic changes in the larynx.
Kosztyła-Hojna, Bożena +6 more
core
Evaluating the Local Response of a Novel Injectable Capsule for Drug Delivery in the Trachea
A novel PLGA polymer capsule was developed for localized pretracheal drug delivery and evaluated for short‐term local tissue safety in a rabbit model. Implant placement was confirmed by ultrasound and was well tolerated over 14 days, with preservation of airway patency, native tracheal architecture, and biomechanical properties.
Denzel Ryan D. Cruz +7 more
wiley +1 more source
Supraglottic Botulinum Toxin Injection Improves Symptoms of Laryngeal Sensory Dysfunction
In this retrospective cohort of 80 patients with refractory laryngeal sensory symptoms, supraglottic botulinum toxin type A significantly improved Laryngeal Hypersensitivity Questionnaire, Reflux Symptom Index, and Cough Severity Index scores at a mean of 5.2 weeks, while Voice Handicap Index‐10 scores remained unchanged.
Daniel Novakovic +3 more
wiley +1 more source
Voice changes in patients with chronic obstructive pulmonary disease
Introduction: Voice changes are not a direct symptom of chronic obstructive pulmonary disease (COPD), but many COPD patients experience voice changes.
Enas Elsayed Mohamed +1 more
doaj +1 more source
Dysphagia and Dysphonia in COVID-19 Patients Hospitalized in the Ward Versus Intensive Care Unit [PDF]
Objectives: COVID-19 was triggered by the severe acute respiratory syndrome coronavirus-2, leading to a pandemic. The risk of developing dysphonia and dysphagia amongst COVID-19 patients is considered to be high.
Akbar Banari +3 more
doaj
Introduction It was reported that voice can carry information about personality and psychological distress. In the current study, the relationship between five‐factor personality traits and psychological distress with voice was enlightened from diverse ...
Mahshid Aghajanzadeh +3 more
doaj +1 more source
INTRODUCTION: Dysphonia is the main symptom of the disorders of oral communication. However, voice disorders also present with other symptoms such as difficulty in maintaining the voice (asthenia), vocal fatigue, variation in habitual vocal fundamental ...
Paulo Eduardo Przysiezny +1 more
doaj +1 more source

